antimicrobial resistance

FDA okays Nabriva’s novel antibiotic Xenleta for pneumonia

https://pharmaphorum.com/news/fda-okays-nabrivas-novel-antibiotic-xenleta-for-pneumonia/

Who will pay the price for inaction on superbugs?

https://pharmaphorum.com/r-d/views-analysis-r-d/who-will-pay-the-price-for-inaction-on-superbugs/

As R&D shrinks, UK trials new payment scheme for antibiotics

https://pharmaphorum.com/news/as-rd-shrinks-uk-trials-new-payment-scheme-for-antibiotics/

AMR research and Matoke Pharma: the pharmaphorum podcast

https://pharmaphorum.com/podcast/amr-research-matoke-pharma-podcast/

Discuss recent developments in bacterial immunotherapy at Superbugs & Superdrugs 2019

https://pharmaphorum.com/partner-content/discuss-recent-developments-in-bacterial-immunotherapy-at-superbugs-superdrugs-2019/

Combating Antifungal Resistance to be discussed at Superbugs & Superdrugs Conference

https://pharmaphorum.com/partner-content/combating-antifungal-resistance-to-be-discussed-at-superbugs-superdrugs-conference/

WHO’s Senior Advisor to speak at 21st Annual Superbugs & Superdrugs Conference

https://pharmaphorum.com/partner-content/whos-senior-advisor-to-speak-at-21st-annual-superbugs-superdrugs-conference/

Challenges including Funding and Lack of Incentives Hinder Antimicrobial Resistance Research

https://pharmaphorum.com/partner-content/challenges-including-funding-and-lack-of-incentives-hinder-antimicrobial-resistance-research/

Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Conference

https://pharmaphorum.com/partner-content/registration-officially-opens-for-the-21st-annual-superbugs-superdrugs-conference/

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search